Рет қаралды 1,892
This educational webinar will give an overview of how AML is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international hematology conferences.
What is new and what does this mean for patients?
We will be joined by:
Dr Mike Dennis, Consultant Haematologist, The Christie NHS Foundation Trust. (UK)
Anne -Pierre Pickaert, Patient Advocate, Acute Leukaemia Advocates Network (France)
This webinar may be useful for people affected by a diagnosis of AML: patients, family members, supporters and advocates.